000 | 01720 a2200493 4500 | ||
---|---|---|---|
005 | 20250512022920.0 | ||
264 | 0 | _c19851218 | |
008 | 198512s 0 0 eng d | ||
022 | _a0002-8614 | ||
024 | 7 |
_a10.1111/j.1532-5415.1985.tb04185.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMohs, R C | |
245 | 0 | 0 |
_aClinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies. _h[electronic resource] |
260 |
_bJournal of the American Geriatrics Society _cNov 1985 |
||
300 |
_a749-57 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrocortisone _xblood |
650 | 0 | 4 | _aInfusions, Parenteral |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemory _xdrug effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeuropsychological Tests |
650 | 0 | 4 |
_aPhysostigmine _xadministration & dosage |
650 | 0 | 4 | _aRadioimmunoassay |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aSomatostatin _xblood |
700 | 1 | _aDavis, B M | |
700 | 1 | _aGreenwald, B S | |
700 | 1 | _aMathé, A A | |
700 | 1 | _aJohns, C A | |
700 | 1 | _aHorvath, T B | |
700 | 1 | _aDavis, K L | |
773 | 0 |
_tJournal of the American Geriatrics Society _gvol. 33 _gno. 11 _gp. 749-57 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1532-5415.1985.tb04185.x _zAvailable from publisher's website |
999 |
_c2871128 _d2871128 |